Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/17 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 148
- 較 2021 年第 1 季 +12
- 總值
- $76.9 億
- 較 2021 年第 1 季 +$1.66 億 (+2.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| CYPHCypherpunk Technologies Inc. | COM | 8,476,496 | $1,390 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 491,332 | $1,387 萬 | 0.2% | +179,659+57.6% | 加碼 | 歷史 |
| CM Life Sciences III Inc125841205 | UNIT 04/30/2028 | 1,250,000 | $1,369 萬 | 0.2% | +1,250,000 | 新進 | – |
| ACCDAccolade, Inc. | COM | 245,741 | $1,335 萬 | 0.2% | −100,000−28.9% | 減碼 | 歷史 |
| CVRXCVRx, Inc. | COM | 440,000 | $1,232 萬 | 0.2% | +440,000 | 新進 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 1,000,000 | $1,053 萬 | 0.1% | 00.0% | 不變 | – |
| CTMXCytomX Therapeutics, Inc. | COM | 1,640,957 | $1,039 萬 | 0.1% | −513,017−23.8% | 減碼 | 歷史 |
| RACBResearch Alliance Corp. II | COM CL A | 1,000,000 | $1,014 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Summit Healthcre Acquistn CoG8566R128 | UNIT 06/03/2026 | 1,000,000 | $1,001 萬 | 0.1% | +1,000,000 | 新進 | – |
| TBIOTelesis Bio Inc. | COM | 425,000 | $935.0 萬 | 0.1% | +425,000 | 新進 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,150,641 | $907.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 375,256 | $903.6 萬 | 0.1% | −69,622−15.6% | 減碼 | 歷史 |
| PRVBProvention Bio, Inc. | COM | 948,481 | $799.6 萬 | 0.1% | −1,903,577−66.7% | 減碼 | 歷史 |
| PSTXPoseida Therapeutics, Inc. | COM | 787,745 | $789.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 755,375 | $739.5 萬 | 0.1% | 00.0% | 不變 | – |
| SILKSilk Road Medical Inc | COM | 147,133 | $704.2 萬 | 0.1% | −192,967−56.7% | 減碼 | 歷史 |
| DRIODarioHealth Corp. | COM NEW | 327,869 | $700.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 320,440 | $679.3 萬 | 0.1% | −150,000−31.9% | 減碼 | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 135,000 | $599.0 萬 | 0.1% | +135,000 | 新進 | 歷史 |
| AKYAAkoya Biosciences, Inc. | COM | 300,000 | $580.2 萬 | 0.1% | +300,000 | 新進 | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 500,000 | $569.0 萬 | 0.1% | 00.0% | 不變 | – |
| MREOMereo BioPharma Group plc | SPON ADS | 1,696,068 | $537.7 萬 | 0.1% | −4,303,932−71.7% | 減碼 | 歷史 |
| Consonance HFW Acquisition CG2445M129 | UNIT 99/99/9999 | 500,000 | $520.0 萬 | 0.1% | 00.0% | 不變 | – |
| PRTAProthena Corp Public Ltd Co | SHS | 100,000 | $514.1 萬 | 0.1% | +100,000 | 新進 | 歷史 |
| Longview Acquisition Corp. II54319Q204 | UNIT 99/99/9999 | 500,000 | $504.0 萬 | 0.1% | 00.0% | 不變 | – |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 450,000 | $459.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 421,641 | $410.7 萬 | 0.1% | −10.0% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 175,000 | $368.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| AMWLAmerican Well Corp | CL A | 290,000 | $364.8 萬 | <0.1% | −65,000−18.3% | 減碼 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 89,283 | $346.9 萬 | <0.1% | +20,000+28.9% | 加碼 | 歷史 |
| CM Life Sciences Inc18978W109 | COM CL A | 227,000 | $318.0 萬 | <0.1% | +100,000+78.7% | 加碼 | – |
| FULCFulcrum Therapeutics, Inc. | COM | 294,118 | $308.2 萬 | <0.1% | +294,118 | 新進 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 300,000 | $300.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| GRTXGalera Therapeutics, Inc. | COM | 254,664 | $250.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| KRROKorro Bio, Inc. | COM | 222,222 | $221.3 萬 | <0.1% | −1,891,439−89.5% | 減碼 | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 133,066 | $191.4 萬 | <0.1% | 00.0% | 不變 | – |
| MOTSMotus GI Holdings, Inc. | COM | 1,800,542 | $187.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SGTXSigilon Therapeutics, Inc. | COM | 125,000 | $134.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 66,655 | $129.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RACEFerrari N.V. | COM | 6,200 | $127.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| EIGREiger BioPharmaceuticals, Inc. | COM | 139,890 | $119.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Butterfly Network, Inc.124155110 | *W EXP 05/27/202 | 233,333 | $112.7 萬 | <0.1% | 00.0% | 不變 | – |
| SC Health CorpG78516401 | *W EXP 99/99/999 | 500,000 | $105.5 萬 | <0.1% | 00.0% | 不變 | – |
| PLXPPLx Pharma Winddown Corp. | COM | 57,459 | $79.3 萬 | <0.1% | −164,721−74.1% | 減碼 | 歷史 |
| TKNOAlpha Teknova, Inc. | COM | 30,000 | $71.2 萬 | <0.1% | +30,000 | 新進 | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 30,753 | $50.5 萬 | <0.1% | −282,547−90.2% | 減碼 | 歷史 |
| PHVSPharvaris N.V. | COM | 27,000 | $50.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 60,000 | $28.3 萬 | <0.1% | +60,000 | 新進 | – |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 1 季之後清倉（17 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALLOAllogene Therapeutics, Inc. | COM | 1,143,790 | $4,038 萬 | 0.5% | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 575,007 | $3,990 萬 | 0.5% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 1,410,305 | $3,639 萬 | 0.5% | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,250,000 | $3,503 萬 | 0.5% | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 797,404 | $2,936 萬 | 0.4% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 850,000 | $1,679 萬 | 0.2% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 270,000 | $603.7 萬 | 0.1% | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 300,000 | $579.0 萬 | 0.1% | 歷史 |
| PHRPhreesia, Inc. | COM | 100,000 | $521.0 萬 | 0.1% | 歷史 |
| Deerfield Healthcare Tech Ac244413209 | UNIT 07/16/2025 | 300,000 | $393.0 萬 | 0.1% | – |
| TXMDTherapeuticsMD, Inc. | COM | 2,750,000 | $368.5 萬 | <0.1% | 歷史 |
| VRAYViewRay, Inc. | COM | 751,748 | $327.0 萬 | <0.1% | 歷史 |
| TLISTalis Biomedical Corp | COM | 250,000 | $321.2 萬 | <0.1% | 歷史 |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 300,000 | $121.2 萬 | <0.1% | – |
| CVMCel Sci Corp | COM PAR NEW | 33,700 | $51.3 萬 | <0.1% | 歷史 |
| SANASana Biotechnology, Inc. | COM | 10,000 | $33.5 萬 | <0.1% | 歷史 |
| Deerfield Healthcare Tech Ac244413100 | COM CL A | 20,000 | $24.2 萬 | <0.1% | – |